Clinical trial
Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis
NCT02062216 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- December 31, 2018
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.